latest news releases from the newsroom
Ericsson: Leading Mobile Wireless Technology Companies call on European Commission to Investigate Qualcomm's Anti-Competitive Conduct
STOCKHOLM, Sweden, Oct. 28, 2005 (PRIMEZONE) -- Broadcom, Ericsson, NEC, Nokia, Panasonic Mobile Communications and Texas Instruments have each filed Complaints to the European Commission requesting that it investigate and stop Qualcomm's anti-competitive conduct in the licensing of essential patents for 3G mobile technology.The companies state that Qualcomm is violating EU competition law and failing to meet the commitments Qualcomm made to international standard bodies around the world that it would license its technology on fair, reasonable and non-discriminatory terms. Absent these commitments, the WCDMA 3G standard would not have been adopted. Qualcomm is infringing these rules by:
Discovery Laboratories, Inc.
Discovery Labs' Surfaxin Granted Orphan Drug Designation for the Treatment of Bronchopulmonary Dysplasia
WARRINGTON, Pa., Oct. 28, 2005 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's lead product, Surfaxin(r), for the treatment of Bronchopulmonary Dysplasia (also known as Chronic Lung Disease, CLD) in premature infants. Surfaxin, a precision-engineered lung surfactant replacement therapy, has received an Approvable Letter from the U.S. FDA for the prevention of Respiratory Distress Syndrome (RDS) in premature infants and is pending approval.
CATENA’S BOARD APPOINTED
Bilia AB has decided to elect the following individuals as the new board of
Catena, currently Bilia Fastigheter AB, Curt Lönnström (chairman), Ingrid
Berggren, Lars Söderblom, Erik Törnberg, Gerard Versteegh and Peter Hallgren
Curt Lönnström is the managing director of Ryda Bruk AB and a member of the
board of companies including Poolia AB, Uniflex AB and Hagströmer & Qviberg AB.
Ingrid Berggren works for Calyon (formerly Credit Agricole Indosuez). Lars
Söderblom is chair
Artelon Nanofibers Successfully Used as Coating on Metal Implants
STOCKHOLM, Sweden, Oct. 28, 2005 (PRIMEZONE) -- Percutaneous implants, i.e. implants going through the skin, are widely used in applications like fracture fixation, anchorage of hearing aids and other prostheses. They offer great value to the patient but a common clinical problem is infections around the skin-penetrating part of the metal implant. Complications like these often require local or systemic treatment with antibiotics and may in more severe cases result in failure of the entire implant.
Trelleborgs' Acquisition of Chase-Walton Elastomers Concluded
STOCKHOLM, Sweden, Oct. 28, 2005 (PRIMEZONE) -- Trelleborg's acquistion of the operations of Chase-Walton Elastomers Inc. has now been concluded. Chase-Walton Elastomers designs, develops and manufactures polymer components in silicone, primarily for the aerospace, medical-technology and biotech industries. Chase-Walton has annual sales of about SEK 100 M, with some 110 employees at production units in Hudson, Massachusetts in the U.S.